Insurer accuses J&J unit of using ‘sham’ patent litigation to thwart generics STAT
The case “shines a light on another potential reason for high drug prices,” says Michael Carrier, a Rutgers University law school professor.
Insurer accuses J&J unit of using ‘sham’ patent litigation to thwart generics STAT
The case “shines a light on another potential reason for high drug prices,” says Michael Carrier, a Rutgers University law school professor.